Latest Protein Spotlight: Whispers

We all depend on cues. Without them, the notion of community would not exist. Cues are the cement of society, and their nature can be very diverse. Birds whistle. Hogs grunt. Plants give off scents. Fish use bioluminescence. Slugs release pheromones. Humans talk.

New discoveries on the impact of lifestyle factors & genetic markers on our lifespan

"Longevity is of interest to us all" this is how Zoltán Kutalik, Group Leader at SIB and Biostatistician at the University Hospital of Lausanne (CHUV) and the University of Lausanne (UNIL) begins his publication in Nature Communications.

First Certificate of Advanced Studies (CAS) in personalized molecular oncology

The University Hospital of Basel is launching a CAS in personalized molecular oncology with the SIB Swiss Institute of Bioinformatics and the University Hospital of Lausanne. First of its kind in Switzerland, this training takes place at a key point in time and matches the growing interest for personalized medicine at the national level, as exemplified by initiatives like the Swiss Personalized Health Network led by the Swiss Academy of Medical Sciences.

From infrastructure planning to implementation, BioMedIT progresses

Update on the Swiss Personalized Health Network (SPHN)

Designed to promote the development of personalized health in Switzerland, the SPHN initiative will lay the foundations to foster research projects in this area, including mechanisms facilitating the nationwide exchange of health-related data. In this context, SIB has been mandated to run SPHN’s Data Coordination Centre (DCC) and is managing the BioMedIT project.

SIB’s Swiss-Prot Group co-director Alan Bridge on the future of biocuration

As announced in May, Alan Bridge is taking up the co-director role of SIB’s Swiss-Prot Group, thus succeeding to Lydie Bougueleret. He gives us his vision of the future for a unique profession, biocuration, and for the Swiss-Prot Group, one of its best-known exponents.

SourceData is making data discoverable

A push for a paradigm change in scientific publication. Bringing to the surface information buried in the figures of scientific papers: this is the purpose of SourceData, an open-access platform developed by EMBO in collaboration with the SIB Swiss Institute of Bioinformatics. SourceData allows researchers and publishers to share figures and their underlying data in a machine-readable, searchable format. This award-winning publishing innovation is highlighted in a Nature Methods paper this week, as well as in the journal’s Editorial.

Latest Protein Spotlight: Seeking past shelter

Nothing can survive without the means to defend itself. If bacteria are unable to protect themselves from freezing temperatures, they perish. If we cannot fight off the flu virus, we pass away. If plants cannot ward off toxic fungi, they wilt and die. In fact, we all spend a lot of time shunning "stresses", of either biological (biotic) origin, or non-biological (abiotic) origin.

A thorough ‘catalogue’ of an aggressive type of childhood cancer

Improving cancer precision therapy requires a greater ability to identify and describe groups of patients who share the same molecular and clinical particularities. An SIB Swiss Institute of Bioinformatics group recently played a pivotal role in building the most thorough ‘catalogue’ of an aggressive type of childhood cancer – thus providing a basis for novel therapeutic treatments.